Advanced Heart Failure
30
6
7
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
3.3%
1 terminated out of 30 trials
85.7%
-0.8% vs benchmark
10%
3 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (30)
Tier - Palliative Care For Patients With Advanced Heart Failure or Cancer
Cardiorenal Syndrome: Characteristics and Prognostic Impact in Advanced Heart Failure
HiCM-188 Cell Therapy in Adults With Advanced Heart Failure Undergoing Heart Bypass Surgery
First in Human Study of the Icoms Flowmaker
Cardiac Cachexia in Advanced Heart Failure
REACTION-VAD Trial: Remote Exercise Training Via Telemedicine in Patients With Long-Term Ventricular Assist Devices
Carmat Total Artificial Heart as a Bridge to Transplant in Patients With Advanced Heart Failure
DuoCor 2 DOMINATE Study
GDF-15 and Early Outcomes After LVAD Implantation
Palliative Care Intervention to Improve Health Related Quality of Life for Patients on Long-Term LVAD Support
CorWave LVAS FIH Study
Tier Palliative Care For Patients With Advanced Heart Failure or Cancer
Multi-Site Feasibility Testing of the Ventricular Assist Device Anticipatory Guidance Tool
Trial of Low-intensity Anticoagulation to Reduce GI or Other Bleeding Complications With Equivalent Therapeutic Efficacy in HeartMate 3 LVAD Patients
Wearables and Artificial Intelligence in Advanced Heart Failure Care
European Clinical Evaluation of the Carmat Total Artificial Heart
Post Market Surveillance of the HeartMate 3 Left Ventricular Assist System in Korea
Hong Kong and Taiwan HM3 PMS
Screening for Advanced Heart Failure IN Stable outPatientS - The SAINTS Study (SAINTS B)
Screening for Advanced Heart Failure Treatment (SEE-HF)